Vilazodone Hydrochloride Tablet, Film Coated
Product Images NDC 51407-916

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vilazodone Hydrochloride (NDC 51407-916). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-915-30lb (Vilazodone HCl 10 mg)

This text provides information about a medication called Vilazodone Hydrochloride Tablet. It contains 10 mg of vilazodone hydrochloride. The usual dosage information can be found in the package insert. The medication is to be dispensed with a Medication Guide and stored between 20°C to 25°C. It is also important to keep the medication out of the reach of children. The medication is produced by GSMS, Incorporated located in Camarillo, California.*

FDA Label Image

51407-916-30lb (Vilazodone HCl 20 mg)

This is information about Vilazodone Hydrochloride Tablets, with each tablet containing 20 mg of vilazodone hydrochloride. The usual dosage information can be found in the package insert. The medication guide should be dispensed to each patient and stored in a child-resistant container at 20° to 25°C. The tablets are film-coated and should be kept out of reach of children. More details are available on the Medication Guide printed at https://gsms.us/.*

FDA Label Image

51407-917-30lb (Vilazodone HCl 40 mg)

This is a medication label for Vilazodone Hydrochloride Tablets containing 40 mg of vilazodone hydrochloride. The label includes instructions for pharmacists to dispense the Medication Guide to each patient, dosage information, storage instructions, and safety warnings. The tablets should be kept in a light-resistant container with a child-resistant closure at 20° to 25°C. The medication is intended for prescription use only and is marketed by GSMS, Incorporated in Camarillo, California.*

FDA Label Image

Formula (Image 1)

FDA Label Image

Fig1 (Image 2)

This appears to be a table showing the change in Cmax and AUC due to PK Fold Change along with 90% confidence intervals for various substances such as Ethanol, CYP3A4 Inhibitors like Ketoconazole, CYP3A4 Inducers like Carbamazepine, and Proton Pump Inhibitors like Pantoprazole. The table also includes changes relative to a reference.*

FDA Label Image

Fig2 (Image 3)

This text provides information about various drug substrates for different enzymes such as CYP3A4, CYP1A2, CYP2D6, CYP2C9, CYP2C19, and P-gp. It also includes pharmacokinetic parameters like AUCp, CRmp, URmp, CLm, Um, Cmax, and references to fold change and confidence intervals. This data can be used to evaluate interactions and effects of these drugs on enzyme activity.*

FDA Label Image

Fig3 (Image 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.